Office of Vice President for Clinical Operations

Medicine & Life Sciences

1. Adrenergic Agents 5%
2. Adrenergic beta-Antagonists 5%
3. Aminophylline 10%
4. Aortic Coarctation 5%
5. Appetite Depressants 5%
6. Arterial Pressure 6%
7. Arteries 5%
8. Aspirin 6%
9. Blood Platelets 6%
10. Blood Pressure 6%
11. Bundle-Branch Block 9%
12. Captopril 14%
13. Cardiac Arrhythmias 7%
14. Cardiogenic Shock 6%
15. Cardiology 9%
16. Cardiovascular Physiological Phenomena 6%
17. Chest Pain 6%
18. Chlamydophila pneumoniae 5%
19. Cholesterol 9%
20. Confidence Intervals 8%
21. Coronary Aneurysm 5%
22. Coronary Artery Bypass 15%
23. Coronary Artery Disease 7%
24. Coronary Disease 9%
25. Coronary Vessels 13%
26. Dancing 5%
27. Diabetic Ketoacidosis 5%
28. diphosphoric acid 5%
29. Dogs 26%
30. Economic Inflation 10%
31. Electrocardiography 10%
32. Heart 5%
33. Heart Block 5%
34. Heart Diseases 6%
35. Heart Failure 14%
36. Heart Rate 5%
37. Heart Valve Diseases 5%
38. Hospitalization 6%
39. Incidence 10%
40. Infarction 21%
41. Inlays 5%
42. Left Ventricular Dysfunction 25%
43. Left Ventricular Function 8%
44. Lung 7%
45. MB Form Creatine Kinase 9%
46. Mortality 12%
47. Myocardial Infarction 100%
48. Myocardial Ischemia 5%
49. Neurofibromatoses 5%
50. Nitrates 7%
51. Nitroglycerin 7%
52. Norepinephrine 5%
53. Occult Blood 5%
54. Pheochromocytoma 5%
55. Placebos 6%
56. Polyethylene Terephthalates 5%
57. Population 5%
58. Pravastatin 10%
59. Pregnancy 12%
60. Propranolol 7%
61. Pulmonary Hypertension 5%
62. Reflex 14%
63. Regional Blood Flow 10%
64. Respiration 9%
65. San Francisco 5%
66. Secondary Prevention 5%
67. Stroke Volume 6%
68. Sudden Cardiac Death 8%
69. Survival 10%
70. Survivors 5%
71. Sympathomimetics 5%
72. Systolic Murmurs 5%
73. Tennis 5%
74. Therapeutics 5%
75. Thrombolytic Therapy 12%
76. Transplants 5%
77. Unstable Angina 13%
78. Vascular Resistance 7%
79. Vasoconstriction 8%
80. Vasodilation 8%
81. Ventricular Fibrillation 5%
82. Ventricular Pressure 6%
83. Ventricular Tachycardia 10%